I found this interesting:
'The Board is currently assessing equity and debt proposals that can ensure Skin Elements has the necessary working capital to support this production growth. The Company will seek shareholder and any other regulatory approvals once details have been finalized.'
So there is not enough working capital? Production started in June of Invisishield after approvals months before? Much like HCT, they use COVID-19 as an excuse. They still pulled in some receipts though. No word at all how long they will be in suspension / stagnant. Nothing new really I think.
Ann: Appendix 4C - quarterly, page-5
Add SKN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.357M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 2988114 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 661008 | 3 |
View Market Depth
| Last trade - 16.12pm 18/11/2024 (20 minute delay) ? |
| SKN (ASX) Chart |
Day chart unavailable